Caxton Associates (New York)’s Diebold Nixdorf Incorporated DBD Stock Holding History
Bought
Maintained
Sold
Other funds holding DBD
BPCM
GI
SI
AA
Caxton Associates (New York)'s DBD Position: Q2 2021 in Review
Caxton Associates (New York) sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2021, closing a stake of 26,788 shares — an estimated $379K sold.
Caxton Associates (New York) first reported a position in DBD in Q1 2021 and held it in 1 quarter. The position peaked at $379K in Q1 2021. 182 funds tracked by Wall St. Rank hold DBD as of Q2 2021.
- Caxton Associates (New York) reported no remaining Diebold Nixdorf Incorporated position as of Q2 2021 after selling out during the quarter.
- Caxton Associates (New York) sold 26,788 Diebold Nixdorf Incorporated shares in Q2 2021, an estimated $379K.
- Caxton Associates (New York) first reported a position in Diebold Nixdorf Incorporated in Q1 2021 and held it in 1 quarter.
- Caxton Associates (New York)'s Diebold Nixdorf Incorporated position peaked at $379K in Q1 2021.
- 182 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2021.
Based on Caxton Associates (New York)'s 13F filing for Q2 2021, filed 16 Aug 2021.